Generic Sweden AB (publ)
STO:GENI
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GENI's stock price target?
Not Available
GENI doesn't have any price targets made by Wall Street professionals.
What is Generic Sweden AB (publ)'s Revenue forecast?
Projected CAGR
12%
For the last 14 years the compound annual growth rate for Generic Sweden AB (publ)'s revenue is 2%. The projected CAGR for the next 3 years is 12%.
What is Generic Sweden AB (publ)'s Operating Income forecast?
Projected CAGR
17%
For the last 14 years the compound annual growth rate for Generic Sweden AB (publ)'s operating income is 24%. The projected CAGR for the next 3 years is 17%.
What is Generic Sweden AB (publ)'s Net Income forecast?
Projected CAGR
16%
For the last 14 years the compound annual growth rate for Generic Sweden AB (publ)'s net income is 24%. The projected CAGR for the next 2 years is 16%.
